Smart Inhalers: Global Markets
| 出版 | BCC Research |
| 出版年月 | 2026年06月 |
| ページ数 | 202 |
| 価格 | 記載以外のライセンスについてはお問合せください |
| シングルユーザ | USD 4,650 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR-24397 |
スマート吸入器の世界市場規模は2025年に59億ドルとなり、2025年から2030年にかけて年平均成長率（CAGR）15.4%で推移し、2030年には121億ドルに達するとBCC Researchでは予測しています。
本レポートの主な内容
- 101のデータ表および45の追加表
- スマート吸入器および関連技術の世界市場に関する詳細な分析
- 世界市場の動向分析（2022年～2024年の実績データ、2025年の推定値、および2030年までの年平均成長率（CAGR）の予測を含む）
- 現在の市場規模の推定と収益予測、および製品タイプ、適応疾患、流通チャネル、地域別の市場シェア分析
- 市場の力学、技術の進歩、規制、将来の展望、およびマクロ経済的要因の影響に関する事実とデータ
- 進化する技術や、医療費償還（リイバースメント）の動向・慣行に関する情報
- ポーターの「ファイブフォース分析」に基づく考察および世界的なサプライチェーン分析
- 主要な登録特許および公開特許のレビュー
- 業界構造の分析（企業のシェアと世界ランキング、戦略的取り組み、M&A活動、ベンチャー資金調達の展望など）
- サステナビリティのトレンドとESG（環境・社会・ガバナンス）への取り組みの概要（消費者の意識、主要企業のESGリスク評価および実践状況に重点を置く）
- 業界の主要企業の企業概要（Aptar.com、AstraZeneca、GSK plc、Novartis AG、CHIESI Farmaceutici S.p.A.、Adherium、Boehringer Ingelheim International GmbHなど）
本レポートは、世界のスマート吸入器市場に関する詳細な情報を提供するものです。2024年のデータを用いて市場動向を分析し、2025年の推定値を示すとともに、2025年から2030年にかけての市場の年平均成長率（CAGR）を予測しています。また、市場の現在および将来の潜在性を強調し、競争環境について詳細に論じています。さらに、規制状況、市場の主要な促進要因、阻害要因、および新たな機会についても検討しています。加えて、スマート吸入器のエコシステムで事業を展開する主要企業の市場シェア分析も含まれています。
本レポートでは、スマート吸入器市場を製品タイプ、適応疾患、および流通チャネル別に区分しています。
地域別では、北米、欧州、アジア太平洋、中東・アフリカ（MEA）、南米に区分しています。地域別の区分においては、米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、日本、中国、韓国、オーストラリア、インドに関する詳細な分析を行っています。市場データについては、基準年である2024年の実績値に加え、2025年の予測値および2030年の予測値を提供しています。
Report Highlights
The global market for smart inhalers was valued at $5.9 billion in 2025 and is estimated to reach $12.1 billion by 2030, at a compound annual growth rate (CAGR) of 15.4% from 2025 through 2030.
Report Includes
- 101 data tables and 45 additional tables
- In-depth analysis of the global market for smart inhalers and related technologies
- Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the current market size and revenue forecasts, accompanied by a corresponding market share analysis based on based on product type, disease indication, distribution channel, and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, prospects, and the impact of macroeconomic variables
- Coverage of evolving technologies and reimbursement trends and practices
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Review of key granted and published patents
- Analysis of the industry structure, including companies’ shares and global rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Company profiles of major players within the industry, including Aptar.com, AstraZeneca, GSK plc, Novartis AG, CHIESI Farmaceutici S.p.A., Adherium, and Boehringer Ingelheim International GmbH
Report Scope
The report provides detailed information on the global smart inhalers market. It analyzes market trends using 2024 data, provides estimates for 2025, and projects a compound annual growth rate (CAGR) from 2025 through 2030 for the global smart inhalers market. The report highlights current and future market potential and provides an in-depth discussion of the competitive landscape. It also examines regulatory scenarios, key market drivers, restraints, and emerging opportunities. The report also includes market share analysis for leading companies operating in the smart inhalers ecosystem.
In this report, the smart inhalers market is segmented by product type, disease indication, and distribution channel.
By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America. The regional segment covered a detailed analysis of the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. Market data is provided for 2024, the base year, with forecasts for 2025 and a 2030 forecast value.
The report aims to:
- Analyze key product types and technology platforms within the smart inhalers market.
- Evaluate the global market size and detailed segmentation.
- Examine major market drivers, restraints, and opportunities.
- Provide comprehensive market forecasts through 2030.
- Assess market share distribution, competitive dynamics, and industry structure.
- Identify potential long-term impacts of digital health, regulatory evolution, and technological innovation on the smart inhalers market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $5.2 billion | ||||||||||||||||
| Market size forecast | $12.1 billion | ||||||||||||||||
| Growth rate | CAGR of 15.4% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product Type, Disease Indication, Distribution Channel | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, Italy, Spain, U.K., Austria, Denmark, the Netherlands, Poland, Sweden, Switzerland, Turkey, China, India, Japan, Australia, South Korea, Malaysia, New Zealand, Singapore, Thailand, Vietnam, Brazil, Argentina | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Current and Future Market Overview
Macroeconomic Factor Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Impact of the Ukraine-Russia War on the Smart Inhalers Industry
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Burden of Asthma and Chronic Respiratory Diseases
High Prevalence of Medication Nonadherence
Regulatory and Digital Health Enablement
Market Restraints
High Costs and Limited Reimbursement Coverage
Limited Long-Term Clinical and Economic Evidence
Patient Engagement Gaps and Digital Divide
Market Opportunities
Advanced Sensing and AI-Enabled Personalized Care
Strategic Pharma Partnerships and Data-Driven Labeling
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Patent Analysis
Overview
Advanced Sensing Technologies
Artificial Intelligence (AI) and Machine Learning (ML)
Digital Biomarkers and Disease Phenotyping
Edge Computing and Federated Learning
Power Management, Miniaturization, and Hardware Innovation
Adaptive Therapy and Closed-Loop Concepts
Clinical Evidence and Real-World Examples
Patent Analysis
Patents, by Year
Patents, by Jurisdiction
Patents, by Leading Inventor
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Market for Smart Inhalers, by Product Type
Key Takeaways
MDI-Based Smart Inhalers
DPI-Based Smart Inhalers
Other Product Types
Global Smart Inhalers Market, by Disease Indication
Key Takeaways
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Other Disease Indications
Global Smart Inhalers Market, by Distribution Channel
Key Takeaways
Retail Pharmacies
Online and Direct-to-Consumer Channel
Hospital Pharmacies
Geographic Breakdown
Global Market for Smart Inhalers by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ADHERIUM
AMIKO DIGITAL HEALTH LTD.
APTAR.COM
ASTRAZENECA
BIOCORP
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CHIESI FARMACEUTICI S.P.A.
COGNITA LABS LLC.
FINDAIR SP. Z O.O
GSK PLC
NOVARTIS AG
NUVOAIR MEDICAL
PERSONAL AIR QUALITY SYSTEMS PVT. LTD.
PRESSPART VERWALTUNGS GMBH
SMART RESPIRATORY PRODUCTS LTD.
Emerging Players in the Smart Inhalers Market
List of Tables
Summary Table : Global Market for Smart Inhalers, by Region, Through 2030
Table 1 : Key U.S. Smart Inhaler Regulatory Precedents
Table 2 : Patents Granted for Smart Inhalers, by Inventor, January 2023 to December 2025
Table 3 : Global Market for Smart Inhalers, by Product Type, Through 2030
Table 4 : Global Market for MDI-Based Smart Inhalers, by Region, Through 2030
Table 5 : Global Market for DPI-Based Smart Inhalers, by Region, Through 2030
Table 6 : Global Market for Other Types of Smart Inhalers, by Region, Through 2030
Table 7 : Global Market for Smart Inhalers, by Disease Indication, Through 2030
Table 8 : Global Market for Smart Inhalers for Asthma, by Region, Through 2030
Table 9 : Global Market for Smart Inhalers for COPD, by Region, Through 2030
Table 10 : Global Market for Smart Inhalers for Other Disease Indications, by Region, Through 2030
Table 11 : Global Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 12 : Global Market for Smart Inhalers in Retail Pharmacies, by Region, Through 2030
Table 13 : Global Market for Smart Inhalers in Online and Direct-to-Consumer Channel, by Region, Through 2030
Table 14 : Global Market for Smart Inhalers in Hospital Pharmacies, by Region, Through 2030
Table 15 : Global Market for Smart Inhalers, by Region, Through 2030
Table 16 : North American Market for Smart Inhalers, by Product Type, Through 2030
Table 17 : North American Market for Smart Inhalers, by Disease Indication, Through 2030
Table 18 : North American Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 19 : North American Market for Smart Inhalers, by Country, Through 2030
Table 20 : U.S. Market for Smart Inhalers, by Product Type, Through 2030
Table 21 : U.S. Market for Smart Inhalers, by Disease Indication, Through 2030
Table 22 : U.S. Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 23 : Canadian Market for Smart Inhalers, by Product Type, Through 2030
Table 24 : Canadian Market for Smart Inhalers, by Disease Indication, Through 2030
Table 25 : Canadian Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 26 : Mexican Market for Smart Inhalers, by Product Type, Through 2030
Table 27 : Mexican Market for Smart Inhalers, by Disease Indication, Through 2030
Table 28 : Mexican Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 29 : European Market for Smart Inhalers, by Product Type, Through 2030
Table 30 : European Market for Smart Inhalers, by Disease Indication, Through 2030
Table 31 : European Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 32 : European Market for Smart Inhalers, by Country, Through 2030
Table 33 : German Market for Smart Inhalers, by Product Type, Through 2030
Table 34 : German Market for Smart Inhalers, by Disease Indication, Through 2030
Table 35 : German Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 36 : U.K Market for Smart Inhalers, by Product Type, Through 2030
Table 37 : U.K. Market for Smart Inhalers, by Disease Indication, Through 2030
Table 38 : U.K. Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 39 : French Market for Smart Inhalers, by Product Type, Through 2030
Table 40 : French Market for Smart Inhalers, by Disease Indication, Through 2030
Table 41 : French Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 42 : Italian Market for Smart Inhalers, by Product Type, Through 2030
Table 43 : Italian Market for Smart Inhalers, by Disease Indication, Through 2030
Table 44 : Italian Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 45 : Spanish Market for Smart Inhalers, by Product Type, Through 2030
Table 46 : Spanish Market for Smart Inhalers, by Disease Indication, Through 2030
Table 47 : Spanish Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 48 : Rest of Europe Market for Smart Inhalers, by Product Type, Through 2030
Table 49 : Rest of Europe Market for Smart Inhalers, by Disease Indication, Through 2030
Table 50 : Rest of Europe Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 51 : Asia-Pacific Market for Smart Inhalers, by Product Type, Through 2030
Table 52 : Asia-Pacific Market for Smart Inhalers, by Disease Indication, Through 2030
Table 53 : Asia-Pacific Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 54 : Asia-Pacific Market for Smart Inhalers, by Country, Through 2030
Table 55 : Chinese Market for Smart Inhalers, by Product Type, Through 2030
Table 56 : Chinese Market for Smart Inhalers, by Disease Indication, Through 2030
Table 57 : Chinese Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 58 : Japanese Market for Smart Inhalers, by Product Type, Through 2030
Table 59 : Japanese Market for Smart Inhalers, by Disease Indication, Through 2030
Table 60 : Japanese Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 61 : Indian Market for Smart Inhalers, by Product Type, Through 2030
Table 62 : Indian Market for Smart Inhalers, by Disease Indication, Through 2030
Table 63 : Indian Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 64 : South Korean Market for Smart Inhalers, by Product Type, Through 2030
Table 65 : South Korean Market for Smart Inhalers, by Disease Indication, Through 2030
Table 66 : South Korean Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 67 : Australian Market for Smart Inhalers, by Product Type, Through 2030
Table 68 : Australian Market for Smart Inhalers, by Disease Indication, Through 2030
Table 69 : Australian Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 70 : Rest of Asia-Pacific Market for Smart Inhalers, by Product Type, Through 2030
Table 71 : Rest of Asia-Pacific Market for Smart Inhalers, by Disease Indication,Through 2030
Table 72 : Rest of Asia-Pacific Market for Smart Inhalers, by Distribution Channel,Through 2030
Table 73 : South American Market for Smart Inhalers, by Product Type, Through 2030
Table 74 : South American Market for Smart Inhalers, by Disease Indication, Through 2030
Table 75 : South American Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 76 : South American Market for Smart Inhalers, by Country, Through 2030
Table 77 : Brazilian Market for Smart Inhalers, by Product Type, Through 2030
Table 78 : Brazilian Market for Smart Inhalers, by Disease Indication, Through 2030
Table 79 : Brazilian Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 80 : Argentine Market for Smart Inhalers, by Product Type, Through 2030
Table 81 : Argentine Market for Smart Inhalers, by Disease Indication, Through 2030
Table 82 : Argentine Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 83 : Rest of South America Market for Smart Inhalers, by Product Type, Through 2030
Table 84 : Rest of South America Market for Smart Inhalers, by Disease Indication,Through 2030
Table 85 : Rest of South America Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 86 : MEA Market for Smart Inhalers, by Product Type, Through 2030
Table 87 : MEA Market for Smart Inhalers, by Disease Indication, Through 2030
Table 88 : MEA Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 89 : MEA Market for Smart Inhalers, by Subregion, Through 2030
Table 90 : Middle Eastern Market for Smart Inhalers, by Product Type, Through 2030
Table 91 : Middle Eastern Market for Smart Inhalers, by Disease Indication, Through 2030
Table 92 : Middle Eastern Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 93 : African Market for Smart Inhalers, by Product Type, Through 2030
Table 94 : African Market for Smart Inhalers, by Disease Indication, Through 2030
Table 95 : African Market for Smart Inhalers, by Distribution Channel, Through 2030
Table 96 : News/Key Developments in the Smart Inhalers Market, 2022–2025
Table 97 : Abbreviations Used in this Report
Table 98 : Report Sources
Table 99 : Adherium: Company Snapshot
Table 100 : Adherium: Financial Performance, FY 2023 and 2024
Table 101 : Adherium: Product Portfolio
Table 102 : Adherium: News/Key Developments, 2024
Table 103 : Amiko Digital Health Ltd.: Company Snapshot
Table 104 : Amiko Digital Health Ltd.: Product Portfolio
Table 105 : Aptar.com: Company Snapshot
Table 106 : Aptar.com: Financial Performance, FY 2023 and 2024
Table 107 : Aptar.com: Product Portfolio
Table 108 : Aptar.com: News/Key Developments, 2023–2024
Table 109 : AstraZeneca: Company Snapshot
Table 110 : AstraZeneca: Financial Performance, FY 2023 and 2024
Table 111 : AstraZeneca: Product Portfolio
Table 112 : AstraZeneca: News/Key Developments, 2024
Table 113 : BioCorp: Company Snapshot
Table 114 : Biocorp: Product Portfolio
Table 115 : BioCorp: News/Key Developments, 2023
Table 116 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 117 : Boehringer Ingelheim International GmbH: Financial Performance, FY 2023 and 2024
Table 118 : Boehringer Ingelheim International GmbH: Product Portfolio
Table 119 : Boehringer Ingelheim International GmbH: News/Key Developments, 2022
Table 120 : CHIESI Farmaceutici S.p.A.: Company Snapshot
Table 121 : CHIESI Farmaceutici S.p.A.: Financial Performance, FY 2023 and 2024
Table 122 : CHIESI Farmaceutici S.p.A.: Product Portfolio
Table 123 : CHIESI Farmaceutici S.p.A.: News/Key Developments, 2025
Table 124 : Cognita Labs LLC.: Company Snapshot
Table 125 : Cognita Labs LLC.: Product Portfolio
Table 126 : FindAir Sp. Z O.O: Company Snapshot
Table 127 : FindAir Sp. Z O.O: Product Portfolio
Table 128 : FindAir Sp. Z O.O: News/Key Developments, 2024
Table 129 : GSK plc: Company Snapshot
Table 130 : GSK plc: Financial Performance, FY 2023 and 2024
Table 131 : GSK plc: Product Portfolio
Table 132 : GSK plc: News/Key Developments, 2025
Table 133 : Novartis AG: Company Snapshot
Table 134 : Novartis AG: Financial Performance, FY 2023 and 2024
Table 135 : Novartis AG: Product Portfolio
Table 136 : NuvoAir Medical: Company Snapshot
Table 137 : NuvoAir Medical: Product Portfolio
Table 138 : NuvoAir Medical: News/Key Developments, 2024
Table 139 : Personal Air Quality Systems Pvt. Ltd.: Company Snapshot
Table 140 : Personal Air Quality Systems Pvt. Ltd.: Product Portfolio
Table 141 : Presspart Verwaltungs GmbH: Company Snapshot
Table 142 : Presspart Verwaltungs GmbH: Product Portfolio
Table 143 : Smart Respiratory Products Ltd.: Company Snapshot
Table 144 : Smart Respiratory Products Ltd.: Product Portfolio
Table 145 : Some Emerging Companies in the Smart Inhalers Market
List of Figures
Summary Figure : Summary Figure: Global Market Shares of Smart Inhalers, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis of the Smart Inhalers Market
Figure 2 : Market Dynamics of Smart Inhalers
Figure 3 : Patents Granted for Smart Inhalers, by Year, January 2023 to December 2025
Figure 4 : Patents Granted for Smart Inhalers, by Leading Jurisdiction, January 2023 to December 2025
Figure 5 : Global Market Shares of Smart Inhalers, by Product Type, 2024
Figure 6 : Global Market Shares of MDI-Based Smart Inhalers, by Region, 2024
Figure 7 : Global Market Shares of DPI-Based Smart Inhalers, by Region, 2024
Figure 8 : Global Market Shares of Other Types of Smart Inhalers, by Region, 2024
Figure 9 : Global Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 10 : Global Market Shares of Smart Inhalers for Asthma, by Region, 2024
Figure 11 : Global Market Shares of Smart Inhalers for COPD, by Region, 2024
Figure 12 : Global Market Shares of Smart Inhalers for Other Disease Indications, by Region, 2024
Figure 13 : Global Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 14 : Global Market Shares of Smart Inhalers in Retail Pharmacies, by Region, 2024
Figure 15 : Global Market Shares of Smart Inhalers in Online and Direct-to-Consumer Channel, by Region, 2024
Figure 16 : Global Market Shares of Smart Inhalers in Hospital Pharmacies, by Region, 2024
Figure 17 : Global Market Shares of Smart Inhalers, by Region, 2024
Figure 18 : North American Market Shares of Smart Inhalers, by Product Type, 2024
Figure 19 : North American Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 20 : North American Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 21 : North American Market Shares of Smart Inhalers, by Country, 2024
Figure 22 : U.S. Market Shares of Smart Inhalers, by Product Type, 2024
Figure 23 : U.S. Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 24 : U.S. Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 25 : Canadian Market Shares of Smart Inhalers, by Product Type, 2024
Figure 26 : Canadian Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 27 : Canadian Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 28 : Mexican Market Shares of Smart Inhalers, by Product Type, 2024
Figure 29 : Mexican Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 30 : Mexican Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 31 : European Market Shares of Smart Inhalers, by Product Type, 2024
Figure 32 : European Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 33 : European Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 34 : European Market Shares of Smart Inhalers, by Country, 2024
Figure 35 : German Market Shares of Smart Inhalers, by Product Type, 2024
Figure 36 : German Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 37 : German Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 38 : U.K. Market Shares of Smart Inhalers, by Product Type, 2024
Figure 39 : U.K. Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 40 : U.K. Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 41 : French Market Shares of Smart Inhalers, by Product Type, 2024
Figure 42 : French Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 43 : French Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 44 : Italian Market Shares of Smart Inhalers, by Product Type, 2024
Figure 45 : Italian Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 46 : Italian Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 47 : Spanish Market Shares of Smart Inhalers, by Product Type, 2024
Figure 48 : Spanish Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 49 : Spanish Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 50 : Rest of Europe Market Shares of Smart Inhalers, by Product Type, 2024
Figure 51 : Rest of Europe Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 52 : Rest of Europe Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 53 : Asia-Pacific Market Shares of Smart Inhalers, by Product Type, 2024
Figure 54 : Asia-Pacific Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 55 : Asia-Pacific Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 56 : Asia-Pacific Market Shares of Smart Inhalers, by Country, 2024
Figure 57 : Chinese Market Shares of Smart Inhalers, by Product Type, 2024
Figure 58 : Chinese Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 59 : Chinese Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 60 : Japanese Market Shares of Smart Inhalers, by Product Type, 2024
Figure 61 : Japanese Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 62 : Japanese Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 63 : Indian Market Shares of Smart Inhalers, by Product Type, 2024
Figure 64 : Indian Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 65 : Indian Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 66 : South Korean Market Shares of Smart Inhalers, by Product Type, 2024
Figure 67 : South Korean Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 68 : South Korean Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 69 : Australian Market Shares of Smart Inhalers, by Product Type, 2024
Figure 70 : Australian Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 71 : Australian Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 72 : Rest of Asia-Pacific Market Shares of Smart Inhalers, by Product Type, 2024
Figure 73 : Rest of Asia-Pacific Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 74 : Rest of Asia-Pacific Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 75 : South American Market Shares of Smart Inhalers, by Product Type, 2024
Figure 76 : South American Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 77 : South American Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 78 : South American Market Shares of Smart Inhalers, by Country, 2024
Figure 79 : Brazilian Market Shares of Smart Inhalers, by Product Type, 2024
Figure 80 : Brazilian Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 81 : Brazilian Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 82 : Argentine Market Shares of Smart Inhalers, by Product Type, 2024
Figure 83 : Argentine Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 84 : Argentine Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 85 : Rest of South America Market Shares of Smart Inhalers, by Product Type, 2024
Figure 86 : Rest of South America Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 87 : Rest of South America Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 88 : MEA Market Shares of Smart Inhalers, by Product Type, 2024
Figure 89 : MEA Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 90 : MEA Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 91 : MEA Market Shares of Smart Inhalers, by Subregion, 2024
Figure 92 : Middle Eastern Market Shares of Smart Inhalers, by Product Type, 2024
Figure 93 : Middle Eastern Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 94 : Middle Eastern Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 95 : African Market Shares of Smart Inhalers, by Product Type, 2024
Figure 96 : African Market Shares of Smart Inhalers, by Disease Indication, 2024
Figure 97 : African Market Shares of Smart Inhalers, by Distribution Channel, 2024
Figure 98 : Global Market Shares of Smart Inhalers, by Company, 2024
Figure 99 : Adherium: Revenue Shares, by Business Unit, FY 2024
Figure 100 : Adherium: Revenue Shares, by Region, FY 2024
Figure 101 : Aptar.com: Revenue Shares, by Business Unit, FY 2024
Figure 102 : Aptar.com: Revenue Shares, by Region, FY 2024
Figure 103 : AstraZeneca: Revenue Shares, by Business Unit, FY 2024
Figure 104 : AstraZeneca: Revenue Shares, by Region, FY 2024
Figure 105 : Boehringer Ingelheim International GmbH: Revenue Shares, by Business Unit, FY 2024
Figure 106 : Boehringer Ingelheim International GmbH: Revenue Shares, by Region, FY 2024
Figure 107 : CHIESI Farmaceutici S.p.A.: Revenue Shares, by Business Unit, FY 2024
Figure 108 : CHIESI Farmaceutici S.p.A.: Revenue Shares, by Region, FY 2024
Figure 109 : GSK plc: Revenue Shares, by Business Unit, FY 2024
Figure 110 : GSK plc: Revenue Shares, by Region, FY 2024
Figure 111 : Novartis AG: Revenue Shares, by Business Unit, FY 2024
Figure 112 : Novartis AG: Revenue Shares, by Region, FY 2024